Aquinnah Pharma gets $0.5m frants from ALS Association
Aquinnah will use the grants to advance the development of lead compounds focusing on the pathophysiology of TDP-43, found in approximately 90% of cases of ALS. ALS is
Aquinnah will use the grants to advance the development of lead compounds focusing on the pathophysiology of TDP-43, found in approximately 90% of cases of ALS. ALS is
The goal of the "CRISPR/Cas9 Genome-Wide sgRNA Library Screening Platform" grant is to develop a validated set of reagents that can be used for specific targeted disruption of
The first product to offer two convenient solutions, the Estroven Intimacy Kit includes a dietary supplement to support a healthy libido* and a vaginal moisturizer designed to foster
NantHealth’s existing cOS, eviti and omics platforms, combined with Harris’ FusionFX® suite of products, delivers on the promise of whole health systems integration and revolutionizes the patient-clinician experience
The transaction provides Panther Biotechnology with a proprietary, multinational patent protected, ligand-drug conjugate technology platform as well as a pipeline of drug product candidates that address unmet medical
"The issuance of this 9th U.S. patent in our global RPE portfolio represents yet another example of the leadership position we have established as pioneers in Regenerative Ophthalmology,"
The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), as part of the National Institutes of Health (NIH), an agency of the United
"Strong partnerships and coordination across our global study base to identify eligible patients and collect tumor samples have led to successful enrollment for the largest clinical trial ever
The new products, Fertility and Lactation, launched in June 2015 at drinkpremama.com and retailers nationwide. "For many, the maternity journey includes the introduction to vitamins, fertility supplements, heartburn,
Leveraging its comprehensive protein library and proprietary in vivo screening technologies, Five Prime identified GITR as one of the most potent inhibitors of tumor growth. GITR is an